Finally, cerebrospinal fluid levels of ACE are decreased in patients with AD in comparison with age-matched controls and correlated with reduced Aβ42 levels, a well-established marker of Aβ amyloid accumulation in the brain [19]. The gene discussed is ACE; the disease is Alzheimer disease.